Dendrimers can be engineered to carry anticancer drugs, genes, or imaging agents directly to cancer cells. This targeted approach helps in reducing the side effects commonly associated with traditional cancer treatments. Dendrimers can be functionalized with ligands that recognize and bind to specific cancer cell receptors, ensuring that the therapeutic agents are delivered precisely where they are needed.